IQV Quote, Financials, Valuation and Earnings

CVS Health Corp. has a net margin of 8.1% compared to IQVIA Holdings, Inc.'s net margin of -3.88%. IQVIA Holdings, Inc.'s return on equity of 20.65% beat CVS Health Corp.'s return on equity of 0.57%.

IQVIA Holdings, Inc. has a consensus price target of $261.15, signalling upside risk potential of 10.84%. On the other hand CVS Health Corp. has an analysts' consensus of $94.76 which suggests that it could grow by 27.3%. Given that CVS Health Corp. has higher upside potential than IQVIA Holdings, Inc., analysts believe CVS Health Corp. is more attractive than IQVIA Holdings, Inc..

IQVIA Holdings, Inc. has a beta of 1.364, which suggesting that the stock is 36.392% more volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.486, suggesting its less volatile than the S&P 500 by 51.445%.

IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.57% to investors and pays a quarterly dividend of $0.67 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. CVS Health Corp. pays out 72.76% of its earnings as a dividend. CVS Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

IQVIA Holdings, Inc. quarterly revenues are $4.1B, which are smaller than CVS Health Corp. quarterly revenues of $102.9B. IQVIA Holdings, Inc.'s net income of $332M is higher than CVS Health Corp.'s net income of -$4B. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 32.35x while CVS Health Corp.'s PE ratio is 194.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 2.60x versus 0.24x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

First Physicians Capital Group, Inc. has a net margin of 8.1% compared to IQVIA Holdings, Inc.'s net margin of --. IQVIA Holdings, Inc.'s return on equity of 20.65% beat First Physicians Capital Group, Inc.'s return on equity of --.

IQVIA Holdings, Inc. has a consensus price target of $261.15, signalling upside risk potential of 10.84%. On the other hand First Physicians Capital Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings, Inc. has higher upside potential than First Physicians Capital Group, Inc., analysts believe IQVIA Holdings, Inc. is more attractive than First Physicians Capital Group, Inc..

IQVIA Holdings, Inc. has a beta of 1.364, which suggesting that the stock is 36.392% more volatile than S&P 500. In comparison First Physicians Capital Group, Inc. has a beta of 0.531, suggesting its less volatile than the S&P 500 by 46.934%.

IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. First Physicians Capital Group, Inc. pays out -- of its earnings as a dividend.

IQVIA Holdings, Inc. quarterly revenues are $4.1B, which are larger than First Physicians Capital Group, Inc. quarterly revenues of --. IQVIA Holdings, Inc.'s net income of $332M is higher than First Physicians Capital Group, Inc.'s net income of --. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 32.35x while First Physicians Capital Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 2.60x versus 1.42x for First Physicians Capital Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UNIVEC has a net margin of 8.1% compared to IQVIA Holdings, Inc.'s net margin of --. IQVIA Holdings, Inc.'s return on equity of 20.65% beat UNIVEC's return on equity of --.

IQVIA Holdings, Inc. has a consensus price target of $261.15, signalling upside risk potential of 10.84%. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings, Inc. has higher upside potential than UNIVEC, analysts believe IQVIA Holdings, Inc. is more attractive than UNIVEC.

IQVIA Holdings, Inc. has a beta of 1.364, which suggesting that the stock is 36.392% more volatile than S&P 500. In comparison UNIVEC has a beta of -0.101, suggesting its less volatile than the S&P 500 by 110.112%.

IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.

IQVIA Holdings, Inc. quarterly revenues are $4.1B, which are larger than UNIVEC quarterly revenues of --. IQVIA Holdings, Inc.'s net income of $332M is higher than UNIVEC's net income of --. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 32.35x while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 2.60x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.

SCWorx Corp. has a net margin of 8.1% compared to IQVIA Holdings, Inc.'s net margin of -185.96%. IQVIA Holdings, Inc.'s return on equity of 20.65% beat SCWorx Corp.'s return on equity of -74.77%.

IQVIA Holdings, Inc. has a consensus price target of $261.15, signalling upside risk potential of 10.84%. On the other hand SCWorx Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings, Inc. has higher upside potential than SCWorx Corp., analysts believe IQVIA Holdings, Inc. is more attractive than SCWorx Corp..

IQVIA Holdings, Inc. has a beta of 1.364, which suggesting that the stock is 36.392% more volatile than S&P 500. In comparison SCWorx Corp. has a beta of 2.027, suggesting its more volatile than the S&P 500 by 102.683%.

IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. SCWorx Corp. pays out -- of its earnings as a dividend.

IQVIA Holdings, Inc. quarterly revenues are $4.1B, which are larger than SCWorx Corp. quarterly revenues of $705.8K. IQVIA Holdings, Inc.'s net income of $332M is higher than SCWorx Corp.'s net income of -$1.3M. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 32.35x while SCWorx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 2.60x versus 0.30x for SCWorx Corp.. Usually stocks with elevated PS ratios are considered overvalued.